About Orcas Pharmaceuticals Private Limited
Data last updated:
Orcas Pharmaceuticals Private Limited is a private limited company based in Pennagaram, Tamil Nadu, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 06 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U52311TZ2012PTC018721. Its GSTIN is 33AABCO7171J1ZD (Tamil Nadu).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹36.9 Lakh. It is led by directors including Manivel Elaiyabharathi and Kannan Shanmugam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pennagaram, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.08 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹4.99 Lakh (net margin 1.2%) and EBITDA of ₹8.32 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 16% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹80 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website orcaspharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSurvey No.377/5 Kadagathur X Road, Kadagathur Post, Pennagaram, Tamil Nadu, India – 636809
- IndustryPharma, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Orcas Pharmaceuticals Private Limited
The main business activity of Orcas Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Orcas Pharmaceuticals Private Limited
Orcas Pharmaceuticals Private Limited is audited by KUMARESAN & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KUMARESAN & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Orcas Pharmaceuticals Private Limited
Orcas Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manivel Elaiyabharathi | Director | 27 Apr 2023 | 3 Years 5 Months | Current |
| Kannan Shanmugam | Director | 06 Sep 2012 | 14 Years 0 Months | Current |
| Ranjana Devi Muniyappan | Director | 10 Feb 2025 | 1 Years 7 Months | Current |
Financials of Orcas Pharmaceuticals Private Limited FY 2025 filings available
Orcas Pharmaceuticals Private Limited reported revenue of ₹4.08 Cr (up 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Orcas Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 19% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Orcas Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.32 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.99 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Orcas Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Orcas Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Orcas Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Orcas Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2025 | Axis Bank Limited | ₹80 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Orcas Pharmaceuticals Private Limited
Orcas Pharmaceuticals Private Limited has a workforce of 9 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Orcas Pharmaceuticals Private Limited
Orcas Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCO7171J1ZD | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Orcas Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orcas Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orcas Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orcas Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Orcas Pharmaceuticals Private Limited
Frequently Asked Questions about Orcas Pharmaceuticals Private Limited
Orcas Pharmaceuticals is an active private limited company based in Pennagaram, Tamil Nadu, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 06 September 2012 (14+ years old) and is registered under CIN U52311TZ2012PTC018721.
Orcas Pharmaceuticals reported revenue of ₹4.08 Cr for FY 2024 (up 19% YoY).
Orcas Pharmaceuticals has 3 current directors:
- Manivel Elaiyabharathi - Director
- Kannan Shanmugam - Director
- Ranjana Devi Muniyappan - Director
Orcas Pharmaceuticals reported a net profit of ₹4.99 Lakh (net margin 1.2%) and EBITDA of ₹8.32 Lakh (EBITDA margin 2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Orcas Pharmaceuticals is 36% over three years and 16% over five years. In the latest year (FY 2024) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Orcas Pharmaceuticals is 33AABCO7171J1ZD, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Orcas Pharmaceuticals is U52311TZ2012PTC018721. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orcas Pharmaceuticals was incorporated on 06 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Coimbatore.
Orcas Pharmaceuticals can be reached through the website orcaspharma.in. Its registered office is in Pennagaram, Tamil Nadu, India.